Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neuren Pharmaceuticals Ltd
NEUCurrent price
16.71 AUD
-0.79 AUD (-4.51%)
Last closed
17.3 AUD
Company
www.neurenpharma.com
ISIN
NZNEUE0001S8
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
2 160 994 270 AUD
Yield for 12 month
+12.75 %
1Y
3Y
5Y
10Y
15Y
NEU
Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide), which has been registered to treat Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid, and in Phase 2 clinical trial for the treatment of Angelman, Pitt Hopkins, and Prader-Will syndromes. In addition, it provides development services; and holds loan funded shares. The company was incorporated in 2001 and is based in Camberwell, Australia. Address: 697 Burke Road, Camberwell, VIC, Australia, 3124
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
42.78 AUDP/E ratio
17.0104Dividend Yield
–Current Year
+235 966 973 AUD
Last Year
+14 806 629 AUD
Current Quarter
+24 750 970 AUD
Last Quarter
+171 944 303 AUD
Current Year
+208 749 760 AUD
Last Year
+14 796 454 AUD
Current Quarter
+6 550 201 AUD
Last Quarter
+156 009 347 AUD
Key Figures NEU
1 year
3 years
5 years
10 years
EBITDA
157 892 607 AUD
Operating Margin TTM
PE Ratio
17.0104
Return On Assets TTM
59.56 %
PEG Ratio
–
Return On Equity TTM
75.51 %
Wall Street Target Price
42.78 AUD
Revenue TTM
196 712 577 AUD
Book Value
1.74 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-61.3 %
Dividend Yield
–
Gross Profit TTM
2 752 143 AUD
Earnings per share
0.98 AUD
Diluted Eps TTM
0.98 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-83.3 %
Profit Margin
60.67 %
Dividend Analytics NEU
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NEU
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
21.11.2017
Dividend Date
–
Stock Valuation NEU
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
17.0104
Forward PE
18.8324
Enterprise Value Revenue
8.5444
Price Sales TTM
11.147
Enterprise Value EBITDA
11.1374
Price Book MRQ
6.4578
Financials NEU
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NEU
For 52 weeks
12.23 AUD
26.4 AUD
50 Day MA
13.79 AUD
Shares Short Prior Month
–
200 Day MA
18.54 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart